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We report a 58-year-old woman with cutaneous adenoid cystic carcinoma arising on the chest treated with Mohs micrographic
surgery. The patient remained tumor-free at 24-month follow-up. To date, only six other cases of cutaneous adenoid cystic
carcinomawerereportedlymanagedbyMohssurgery.Cutaneousadenoidcysticcarcinomahaslowpotentialfordistantmetastasis
but is notorious for its aggressive inﬁltrative growth pattern, frequent perineural invasion, and high risk of local recurrence after
excision. We propose that Mohs surgery is an ideal method to achieve margin-free removal of cutaneous adenoid cystic carcinoma.
A brief literature review is provided.
1.Introduction
Adenoid cystic carcinoma (ACC) is commonly known as a
malignant neoplasm of salivary glands in the head and neck
region [1]. Rarely, ACC arises directly in the skin, for which
wide local excision is the standard treatment. Cutaneous
ACC has low potential for distant metastasis but is locally
aggressive. Perineural invasion has been reported in 76% of
cases with a local recurrence of 44% following traditional
surgical excision [2], warranting a better management
modality. We propose that a margin-free excision achieved
by Mohs surgery is theoretically superior to traditional wide
local excision. A brief literature review with regard to clinical
presentation, histopathology, and treatment of cutaneous
ACC is provided.
2.CaseReport
A 58-year-old, otherwise healthy, Caucasian female was
referred to the Department of Dermatology at the University
of Wisconsin for treatment of a biopsy proven adenoid cystic
carcinoma on the right mid-chest. She had a lesion of “basal
cell carcinoma” surgically excised on her right mid-chest 14
years previously. The actual slides of the previous excision
werenotretrievable,whilethepathologyreportdidstatethat
the lesion was “a basal cell carcinoma which in some areas
presents gland-like formations, adenoid cystic characteristics
and focal areas of keratinization, but it predominantly is an
adenoid basal cell carcinoma.” The patient had done well
untiloneyearpriortothereferralwhenshenotedtwotender,
ﬂesh-colored nodules adjacent to the scar. A punch skin
biopsy conﬁrmed the diagnosis of adenoid cystic carcinoma
concerning for its inﬁltrative growth pattern and perineural
invasion.
A thorough preoperation physical examination revealed
ahealthy-appearingCaucasianfemalewithanapproximately
15 × 15mm, poorly deﬁned, tender, erythematous patch
with focal crust and a hypopigmented scar notable on
the right mid-sternum region (Figure 1). There was no
lymphadenopathy or organomegaly.
The patient underwent Mohs surgery for excision of the
tumor. The specimens were processed using fresh frozen tis-
sue stained with hematoxylin and eosin. It revealed an inﬁl-
trative dermal tumor composed of basaloid cells arranged in
cords,nodules, andcribriformislands embedded inaﬁbrous
stroma, with a lack of continuity with the surface epidermis.
Prominent glandular and ductal diﬀerentiation and cystic
spaces containing mucinous materials, and eosinophilic2 Journal of Oncology
Figure 1: Clinical morphology prior to the Mohs surgery for a
b i o p s y - p r o v e nA C C :A5 8 - y e a r - o l dw o m a nw i t hap o o r l yd e ﬁ n e d
erythematous patch on the mid-chest, measuring about 15mm
approximately. Note focal crust and a hypopigmented scar within
thepatch.AnadenoidBCCoftherightchestwastreatedbyexcision
14 years earlier. ACC: adenoid cystic carcinoma, BCC: basal cell
carcinoma.
Figure 2:MicroscopicﬁndingoftypicalACCcharacterizedbymul-
tiple glandular and ductal structures in the deep dermis. There are
multiple cysts with some being clear and others with eosinophilic
materials (Fresh frozen tissue, H & E, original magniﬁcation ×40).
ACC: adenoid cystic carcinoma.
globules of amorphous material were noted (Figure 2). The
characteristic cribriform pattern was better appreciated at
a higher magniﬁcation (Figure 3). Interestingly, the cells
lining the cyst showed cytoplasmic blebbing reminiscent of
apocrine-like decapitation secretion (Figure 4). The speci-
mens were also submitted for permanent sections, which
clearly demonstrated several foci of basaloid tumor cells
situated adjacent to nerves (Figure 5). A tumor-free plane
was achieved in two stages down to the subcutaneous fat
with a ﬁnal defect of 31 × 24mm, and the defect was closed
primarily. Adjuvant radiation was not given.
To further rule out an extracutaneous primary site of
the tumor and search for evidence of metastasis, additional
work-up was completed including a breast examination,
mammogram, computed tomographic (CT) scans of the
head, neck, chest, and abdomen, and head and neck
Figure 3: High magniﬁcation demonstrating characteristic cribri-
form pattern in which multiple cysts are embedded in an island of
basaloidcells.Threerepresentativecystsareshownbyarrows(Fresh
frozen tissue, H & E, original magniﬁcation ×100).
Figure4:Thecystliningshowingcytoplasmicblebbingreminiscent
of apocrine-like decapitation secretion within the cyst (Fresh frozen
tissue, H & E, original magniﬁcation ×400).
examination by an otolaryngologist. All were within normal
limits.Thepatientisnow24monthspostoperative,andthere
is no sign of local recurrence or distant metastasis.
The authors acknowledge that for our patient, the Mohs
excision of the tumor preceded the work-up for possible
extracutaneous sources. The work-up was slightly delayed
due to prior-authorization processes involved with her
insurance company. We wish to emphasize that ideally it is
advisabletocompletetheentirework-uppriortoexcision,in
ordertoexcludeanyextracutaneoussourceandthusconﬁrm
the diagnosis of primary cutaneous ACC.
3. Discussion
ACC is most commonly seen as a neoplasm of the major
and minor salivary glands. It can also arise from a variety of
primary sites, including the external auditory canal, lacrimal
gland, respiratory tract, uterus, cervix, vulva, breast, thymus,
prostate, esophagus, and skin [3, 4]. When ACC arises
directly in the skin, it is considered primary cutaneousJournal of Oncology 3
n
Figure 5: Several foci of ACC are situated adjacent to nerves (n)
as indicated by arrows (Paraﬃn-embedded tissue, H & E, original
magniﬁcation ×200). ACC: adenoid cystic carcinoma.
ACC, to be diﬀerentiated from a metastasis or direct
extension of a salivary gland ACC to the skin. Only primary
cutaneous ACC is relevant to our discussion, therefore, if
not otherwise speciﬁed, we will use the term cutaneous
ACC for simplicity. Cutaneous ACC is a rare tumor with
histological features closely resembling ACC of the salivary
glands. Therefore, cutaneous and extracutaneous ACC can
only be distinguished based on clinical grounds and the
diagnosis of cutaneous ACC can only be established by a
lack of any history or current evidence of ACC from an
extracutaneous source. This has paramount signiﬁcance as
the ACC of salivary glands is an aggressive tumor in which
local recurrence and widespread metastases result in death
in the majority of patient; whereas cutaneous ACC tends
to run an indolent course despite a high tendency for local
recurrence [2].
Cutaneous ACC was ﬁrst reported by Boggio in 1975 [5].
To date, just over 50 cases have been published in the English
language literature. According to a recent review paper by
Naylor et al. [2], the mean reported age of onset is 59 years,
with a slight male predominance (male 57%). Excluding
the external auditory canal, the scalp is the most common
location, accounting for 41% of all cases. Other locations
include the chest, abdomen, back, eyelid, and perineum.
Cutaneous ACC often presents as a ﬁrm, slow-growing, ill-
deﬁned nodule or tumor that may be asymptomatic, or with
symptoms including tenderness, pruritus, and secondary
alopecia. Perineural invasion, a risk factor for recurrence,
is seen in 76% of cases. Recurrence is documented in 44%
of cases treated by wide local excision with an average
follow-up length of 58 months. Distant metastasis is rare. If
metastasis does occur, lymph nodes and lung are the sites of
predilection.
MicroscopicﬁndingsofcutaneousACCarecharacterized
by basaloid cells in the mid to deep dermis, arranged in
cords and islands forming tubular structures and cribriform
patterns, usually with a lack of connection to the overlying
epidermis or adnexal structures [6, 7]. There may be
small cystic spaces containing mucinous material that stains
positively for hyaluronic acid. The lumina of the tubular
structures and the surrounding stroma may contain mucin
or eosinophilic necrotic cells. True lumina are surrounded
by prominent basement membrane material, which is PAS
positive, diastase-resistant [6, 7]. Perineural invasion is often
seen [6, 7].
Whether cutaneous ACC is a tumor of eccrine or
apocrine origin has not been determined. There is some
observational evidence suggesting that this tumor might be
apocrineinorigin.ACCoftenarisesfromceruminousglands
oftheexternalearcanal,whicharemodiﬁedapocrineglands.
Histologically, cutaneous ACC must be diﬀerentiated
from adenoid basal cell carcinoma (BCC). Adenoid BCC
also may demonstrate a cribriform pattern with areas of
cystic degeneration and abundant mucin. However, it can
be diﬀerentiated from cutaneous ACC by its continuity
with the epidermis or adjacent hair follicle, the presence of
peripheral palisading and retraction artifact, and often the
lack of perineural invasion. Immunohistochemical studies
may assist in further diﬀerentiating adenoid BCC from ACC.
For instance, in contrast to adenoid BCC, cutaneous ACC
oftenstainspositivelyforS-100,epithelialmembraneantigen
(EMA) and is variably positive with carcinoembryonic
antigen (CEA) [2, 3, 8]. Our patient had a lesion diagnosed
as an adenoid BCC on the chest treated many years earlier
at an outside clinic but no tissue blocks were available for
further review. Therefore, we favor but cannot conﬁrm that
the lesion was an ACC from the beginning.
Another close mimicker of cutaneous ACC is muci-
nous carcinoma of the skin which typically shows islands
of basaloid eccrine cells embedded in lakes or pools of
mucin separated by ﬁbrous septa [9–12]. The mucin is
hyaluronidase resistant and sialidase labile, indicting that it
is a sialomucin, as apposed to the hyaluronic acid seen in
cutaneous ACC. It is worth mentioning that there is a similar
termof“adenocysticcarcinoma”thatisanolderterminology
referring to mucinous carcinoma of the skin [11, 13], but
not adenoid cystic carcinoma. The use of this terminology
is not recommended since it adds more confusion to the
classiﬁcation of sweat gland tumors [14].
Histological diﬀerential diagnosis of ACC should also
include primary cutaneous cribriform apocrine carcinoma,
which is a rare, low-grade cutaneous apocrine carcinoma.
Microscopically primary cutaneous cribriform apocrine car-
cinoma is a nonencapsulated dermal tumor with an exten-
sive cribriform pattern formed by multiple interconnected
basophilic epithelial cells that are arranged in solid nests or
tubular structures, and many small round spaces in between
[15, 16]. As opposed to cutaneous ACC, basophilic aggrega-
tionsaswellasspaceswithinareoftenmorevariedinsizeand
shape, cells are more interconnected, true elongated tubules,
but no deposition of basement membrane material, are
observed, and neoplastic cells contain pleomorphic rather
than monomorphous nuclei. No perineural or intravascular
invasion is seen. No metastatic potential or postexcision
recurrence has been associated with this tumor, which sets
it apart from more aggressive cutaneous ACC [16].
The standard treatment for cutaneous ACC is wide local
excision with tumor-free margins established by permanent
sections [3, 7]. Adjuvant therapy with local radiation is4 Journal of Oncology
Table 1: Cases of primary cutaneous adenoid cystic carcinoma treated with mohs micrographic surgery.




[17]F / 6 8 Sx for ACC
5y r sa g o
Lump in a scar Back Permanent (−)( −) None 18
[18]M / 6 5 1y r Lump Scalp Fresh frozen∗ (−)( −) None 10




Tender scar Scalp Fresh frozen (−)( −) None 18
[20]F / 5 7 1y r Nodule Scalp Fresh frozen (−)( −) Local rad 28
[21]F / 6 2 Months Painless nodule Scalp NS (+) (−) None 6
[22]M / 5 9 1y r Asymptomatic nodule Eyelid NS (+) (−) None 12
Our case F/58 Sx for BCC
14 yrs ago
Tender nodules in a scar Chest Fresh frozen and permanent (+) (−) None 24
AAC: adenoid cystic carcinoma; BCC: basal cell carcinoma; F: female; F/U: follow-up; LN: lymph node; M: male; m: months; NS: not stated; PNI: perineural
invasion; rad: radiation; Ref: reference; Sx: surgery; yrs: years; ∗: Stained with toluidine blue technique.
utilized by some authors [17], although no studies have
demonstrated that radiation decreases the risk of local
recurrence. Chemotherapy has been used in patients with
distant metastases [17, 18].
Only 7 cases [19–24], including the current case, have
been managed by Mohs surgery (Table 1), accounting for
14% of total reported cases. Cutaneous ACC has low poten-
tial for distant metastasis while locally being inﬁltrative with
frequent perineural invasion, making it an ideal indication
for Mohs surgery. The high local recurrence rate of 44% fol-
lowingtraditionalwideexcisionsuggestsincompleteremoval
of the tumor at the initial excision, despite negative margins
established by routine histology. Discontinuous perineural
extension is seen in cutaneous ACC, which may contribute
to false-negative margins leading to a high recurrence rate
[25, 26]. Experience with other more common cutaneous
malignancies that may also exhibit perineural invasion, such
as squamous cell carcinoma and basal cell carcinoma, has
demonstrated the increased sensitivity in the detection of
perineural invasion and the lower rates of recurrence using
Mohssurgerywhencomparedtotraditionalsurgicalexcision
[27–29], leading us to propose that Mohs surgery should be
the treatment of choice for cutaneous ACC.
It is worth clarifying the term “discontinuous perineural
extension.” While tumors normally spread in a continuous
manner, they may spread asymmetrically along the nerve.
Also, tissue manipulation for horizontal sections during
Mohs surgery may distort a nerve and result in “skip-
areas” [25]. Therefore, when tumors invade nerves, Mohs
surgery has its limitation in identifying perineural invasion
conclusively due to possible false “skip areas” or the so-
called “discontinuous perineural extension.” Nevertheless,
Mohs surgery, by examining 100% of the surgical margin
utilizing horizontal sections, still has increased sensitivity
as compared to routine histological processing, in which
equivalent to 0.01% of the specimen surface area is evaluated
[30, 31]. As perineural inﬂammation and “skip areas” due to
tissue processing may indicate proximal perineural invasion,
some authors advocate the removal of an additional Mohs
layer after tumor-free margins are obtained [32, 33]. We
would like to share our experience in managing cutaneous
malignancies with perineural invasion in general. If there
is signiﬁcant perineural invasion then an additional Mohs
l a y e ri sh e l p f u lt oo b t a i nad o u b l en e g a t i v ec o n ﬁ r m a t i o n .
Also, if there are pre-existing “skip areas” noted on the Mohs
excision, then an additional layer needs to be considered. We
recommend local radiation therapy only as a last resort when
it is not possible to surgically remove the malignant tumor,
because wound healing after local radiation therapy is poor.
Some authors have questioned whether routine hema-
toxylin and eosin staining of freshfrozen sectionsfromMohs
surgery provides optimal visualization of tumor margins in
the treatment of cutaneous ACC. Lang et al. preferred to
use permanent sections instead [19]. Given that cutaneous
ACC is rich in mucin, Chesser et al. proposed to use fresh
frozen sections stained with toluidine blue, which stains
mucin metachromatically, to better deﬁne tumor margins
[20]. In our hands, fresh frozen sections stained with routine
hematoxylin and eosin seem to provide suﬃcient micro-
scopic accuracy as shown in Figures 2–4. Nevertheless, we
submitted tissue for permanent sections for reconﬁrmation.
Based on the nature of cutaneous ACC and the success
rate of Mohs surgery in other cutaneous malignancies that
exhibit perineural invasion, we propose that Mohs surgery is
superior to wide local excision to achieve a more complete
excision of this tumor and to reduce the rate of local
recurrence. In the seven cases treated by Mohs surgery, there
has been no local recurrence with a follow-up range of 10–
28 months. However, a limited case number and insuﬃcient
follow-up period does not allow us to draw a deﬁnitive
conclusion. We hope to see more cases managed by Mohs
surgery, so that one might be able to compare whether
there is indeed a lower recurrence rate in cases treated with
Mohssurgeryasopposedtowidelocalexcision.Additionally,
since recurrence of cutaneous ACC can occur as late as
35 years postexcision [2], all patients with cutaneous ACC
deserve life-long follow-up for possible recurrence. Finally,
we propose that when surgically removing an adenoid BCC,Journal of Oncology 5
all cancerous tissue are submitted for permanent sections for
special immunostains to rule out the possibility of ACC or
mucinous carcinoma of the skin.
References
[1] A. J. Khan, M. P. Digiovanna, D. A. Ross, et al., “Adenoid
cystic carcinoma: a retrospective clinical review,” International
Journal of Cancer, vol. 96, no. 3, pp. 149–158, 2001.
[ 2 ]E .N a y l o r ,P .S a r k a r ,C .S .P e r l i s ,D .G i r i ,D .R .G n e p p ,
and L. Robinson-Bostom, “Primary cutaneous adenoid cystic
carcinoma,” Journal of the American Academy of Dermatology,
vol. 58, no. 4, pp. 636–641, 2008.
[3] T. H. van der Kwast, V. D. Vuzevski, F. Ramaekers, M. T.
Bousema,andT.VanJoost,“Primarycutaneousadenoidcystic
carcinoma: case report, immunohistochemistry, and review of
theliterature,”TheBritishJournalofDermatology,vol.118,no.
4, pp. 567–577, 1988.
[4] J. B. Lawrence and M. T. Mazur, “Adenoid cystic carcinoma:
a comparative pathologic study of tumors in salivary gland,
breast, lung, and cervix,” Human Pathology, vol. 13, no. 10, pp.
916–924, 1982.
[5] R.Boggio,“Letter:adenoidcysticcarcinomaofscalp,”Archives
of Dermatology, vol. 111, no. 6, pp. 793–794, 1975.
[6] J. T. Headington, R. Teears, J. E. Niederhuber, and R. P.
Slinger, “Primary adenoid cystic carcinoma of skin,” Archives
of Dermatology, vol. 114, no. 3, pp. 421–424, 1978.
[7] P. H. Cooper, G. L. Adelson, and W. H. Holthaus, “Primary
cutaneousadenoidcysticcarcinoma,”Archives of Dermatology,
vol. 120, no. 6, pp. 774–777, 1984.
[8] M. R. Wick and P. E. Swanson, “Primary adenoid cystic
carcinoma of the skin. A clinical, histological, and immuno-
cytochemical comparison with adenoid cystic carcinoma
of salivary glands and adenoid basal cell carcinoma,” The
American Journal of Dermatopathology, vol. 8, no. 1, pp. 2–13,
1986.
[9] J. T. Headington, “Primary mucinous carcinoma of skin.
Histochemistry and electron microscopy,” Cancer, vol. 39, no.
3, pp. 1055–1063, 1977.
[10] J. D. Wright and R. L. Font, “Mucinous sweat gland adenocar-
cinoma of eyelid. A clinicopathologic study of 21 cases with
histochemicalandelectronmicroscopicobservations,”Cancer,
vol. 44, no. 5, pp. 1757–1768, 1979.
[11] S. Mendoza and E. B. Helwig, “Mucinous (adenocystic)
carcinoma of the skin,” Archives of Dermatology, vol. 103, no.
1, pp. 68–78, 1971.
[12] C. Urso, R. Bondi, M. Paglierani, A. Salvadori, C. Anichini,
and A. Giannini, “Carcinomas of sweat glands: report of 60
cases,” Archives of Pathology & Laboratory Medicine, vol. 125,
no. 4, pp. 498–505, 2001.
[13] T. L. Geraci, S. Jenkinson, L. Janis, and R. Stewart, “Mucinous
(adenocystic) sweat gland carcinoma of the great toe,” The
Journal of Foot Surgery, vol. 26, no. 6, pp. 520–523, 1987.
[14] V. A. White, “Inappropriate use of the term “adenocystic” to
refer to “adenoid cystic” carcinoma of the lacrimal gland,”
Archives of Ophthalmology, vol. 116, no. 12, p. 1698, 1998.
[15] H. Adamski, J. L. Lan, S. Chevrier, B. Cribier, E. Watier, and J.
Chevrant-Breton, “Primary cutaneous cribriform carcinoma:
a rare apocrine tumour,” Journal of Cutaneous Pathology, vol.
32, no. 8, pp. 577–580, 2005.
[ 1 6 ]A .R u t t e n ,H .K u t z n e r ,T .M e n t z e l ,e ta l . ,“ P r i m a r yc u t a -
neous cribriform apocrine carcinoma: a clinicopathologic
and immunohistochemical study of 26 cases of an under-
recognized cutaneous adnexal neoplasm,” J o u r n a lo ft h e
American Academy of Dermatology, vol. 61, no. 4, pp. 644–651,
2009.
[17] N. Kato, K. Yasukawa, and T. Onozuka, “Primary cutaneous
adenoid cystic carcinoma with lymph node metastasis,” The
American Journal of Dermatopathology, vol. 20, no. 6, pp. 571–
577, 1998.
[18] S. Ikegawa, T. Saida, H. Obayashi, et al., “Cisplatin combina-
tion chemotherapy in squamous cell carcinoma and adenoid
cystic carcinoma of the skin,” The Journal of Dermatology, vol.
16, no. 3, pp. 227–230, 1989.
[19] P.G.LangJr.,J.S.Metcalf,andJ.C.Maize,“Recurrentadenoid
cystic carcinoma of the skin managed by microscopically con-
trolled surgery (Mohs surgery),” The Journal of Dermatologic
Surgery and Oncology, vol. 12, no. 4, pp. 395–398, 1986.
[20] R. S. Chesser, D. E. Bertler, J. E. Fitzpatrick, and J. R. Mellette,
“Primary cutaneous adenoid cystic carcinoma treated with
Mohs micrographic surgery toluidine blue technique,” The
Journal of Dermatologic Surgery and Oncology, vol. 18, no. 3,
pp. 175–176, 1992.
[21] A. L. Krunic, S. Kim, M. Medenica, A. E. Laumann, K. Soltani,
and J. C. Shaw, “Recurrent adenoid cystic carcinoma of the
scalp treated with Mohs micrographic surgery,” Dermatologic
Surgery, vol. 29, no. 6, pp. 647–649, 2003.
[22] J. C. Fueston, H. M. Gloster, and D. F. Mutasim, “Primary
cutaneous adenoid cystic carcinoma: a case report and
literature review,” Cutis, vol. 77, no. 3, pp. 157–160, 2006.
[23] J. Barnes and C. Garcia, “Primary cutaneous adenoid cystic
carcinoma: a case report and review of the literature,” Cutis,
vol. 81, no. 3, pp. 243–246, 2008.
[24] R. Sammour, P. Lafaille, V. Joncas, et al., “Adenoid cystic
carcinoma of the eyelid: a rare cutaneous tumor treated with
Mohs micrographic surgery,” Dermatologic Surgery, vol. 35,
no. 6, pp. 997–1000, 2009.
[ 2 5 ]A .M .F e a s e l ,T .J .B r o w n ,M .A .B o g l e ,J .A .T s c h e n ,a n dB .
R. Nelson, “Perineural invasion of cutaneous malignancies,”
Dermatologic Surgery, vol. 27, no. 6, pp. 531–542, 2001.
[26] L. Norberg-Spaak, I. Dardick, and T. Ledin, “Adenoid cys-
tic carcinoma: use of cell proliferation, BCL-2 expression,
histologic grade, and clinical stage as predictors of clinical
outcome,” Head & Neck, vol. 22, no. 5, pp. 489–497, 2000.
[27] P. A. Matorin and R. F. Wagner Jr., “Mohs micrographic
surgery: technical diﬃculties posed by perineural invasion,”
International Journal of Dermatology, vol. 31, no. 2, pp. 83–86,
1992.
[28] T. L. Barrett, H. T. Greenway Jr., V. Massullo, and C. Carlson,
“Treatment of basal cell carcinoma and squamous cell carci-
nomawithperineuralinvasion,”AdvancesinDermatology,vol.
8, pp. 277–304, 1993.
[29] T. L. Schroeder, D. F. Mac Farlane, and L. H. Goldberg,
“Painasanatypicalpresentationofsquamouscellcarcinoma,”
Dermatologic Surgery, vol. 24, no. 2, pp. 263–266, 1998.
[30] J. M. Abide, F. Nahai, and R. G. Bennett, “The meaning of
surgical margins,” Plastic and Reconstructive Surgery, vol. 73,
no. 3, pp. 492–497, 1984.
[31] C. Otley and R. K. Roenigk, “Mohs surgery,” in Dermatology,
J. Bolognia, J. L. Jorizzo, and R. P. Rapini, Eds., pp. 2269–2279,
Mosby Elsevier, Amsterdam, The Netherlands, 2008.
[32] C. S. Birkby and D. C. Whitaker, “Management considerations
for cutaneous neurophilic tumors,” The Journal of Dermato-
logic Surgery and Oncology, vol. 14, no. 7, pp. 731–737, 1988.
[33] D. Ratner, L. Lowe, T. M. Johnson, and D. J. Fader, “Perineural
spread of basal cell carcinomas treated with Mohs micro-
graphic surgery,” Cancer, vol. 88, no. 7, pp. 1605–1613, 2000.